QD Vision Purchases Quantum Dot Patent Portfolio from Motorola

QD Vision, developer of Quantum Light™ nanotechnology-based products for solid state lighting and displays, today announced it has purchased from Motorola a patent portfolio pertaining to the use of quantum dot technology in display and lighting products.

The addition of this portfolio augments QD Vision’s position in quantum dot intellectual property. Included in the acquisition is U.S. Patent No. 5,442,254 of Jaskie, one of the earliest patents on the use of photoluminescent quantum dots in product applications, and pending applications relating to the use of quantum dots to a wide variety of display applications, including LCD backlight units. Prior to this acquisition, QD Vision’s position in quantum dot intellectual property already included nine issued patents and more than 130 patents pending originating at MIT and QD Vision.

QD Vision is developing Quantum Light™ solutions for display backlight units (BLUs) used in several markets, including cell phones, laptops, and TVs, and plans to ship its first products in 2011. The company currently sells its Quantum Light(TM) optic product to the solid state lighting industry. All QD Vision products integrate cutting-edge technologies in nanotech materials, spanning chemistry, manufacturing methods, device designs and applications.

“As we continue to develop new products for solid state lighting and displays based on quantum dot technology, we are building one of the strongest patent portfolios in the industry,” said Dan Button, QD Vision President and CEO. “This Motorola patent portfolio will be added to the vast wealth of intellectual property we already possess, which will enable us to maintain our market leading positions with our existing and future products.”

Source: http://www.qdvision.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.